If a pharmaceutical company aims to reduce chronic neuropathic pain by enhancing descending modulation, which consequence follows from stimulating the periaqueductal gray (PAG) region?

💡 Explanation

Stimulating the PAG activates descending pain modulation pathways, causing release of endorphins and enkephalins that inhibit nociceptor signal transmission in the spinal cord. Therefore, pain signals are reduced, rather than amplified, and pain thresholds are decreased rather than increased.

• A weightlifter experiences muscle fatigue during a maximal lift. Which mechanism explains why lactate accumulation contributes to this phenomenon in anaerobic conditions?
• Which consequence results when mucostatic gel residue coats taste receptors?
• During strenuous exercise, why does the ventilation-perfusion ratio (V/Q) mismatch sometimes lead to arterial hypoxemia despite increased alveolar ventilation?
• As sound exposure accumulates during a person's life, what causes high-frequency hearing loss typically appearing before low-frequency loss?
• If a patient experiences diminished tactile acuity following a stroke affecting the somatosensory cortex, which adaptation is most likely employed to improve object recognition by touch?
• An individual with cirrhosis develops ascites and esophageal varices. Why does increased hepatic fibrosis contribute to these complications?